This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

An 18-Month Study of 60 Patients

Samuel L. Moschella, MD; Michael A. Greenwald, MD

Arch Dermatol. 1973;107(3):363-368.

Abstract
An attempt was made to evaluate the therapeutic effectiveness and toxicity of hydroxyurea administered in intermittent courses over a period of 18 months for the treatment of 60 patients with severe or incapacitating psoriasis. Hydroxyurea produced satisfactory results (good to excellent) in 63% of the patients in the first six weeks of therapy and remained similarly effective in 50% of the patients given intermittent therapy over the 18-month study period. The eruption relapses almost always upon the discontinuance of the drug with the development of resistance to further therapy in 13% of patients. Fifteen percent of the patients experienced severe enough drug toxicity to necessitate its discontinuance. Hydroxyurea should be reserved for patients who have extensive psoriasis and need clinical response because of special circumstances.

Author Affiliations
Boston

From the Department of Allergy and Dermatology, Lahey Clinic Foundation, Boston.

Footnotes
Accepted for publication Sept 28, 1972.

Reprint requests to Department of Dermatology, Lahey Clinic Foundation, 605 Commonwealth Ave, Boston 02215 (Dr. Moschella).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Systemic Drug Therapy for Psoriasis: The Most Critical Issues
Wolverton
Arch Dermatol 1991;127:565-568.
ABSTRACT  

Hydroxyurea and Pain in Psoriatic Lesions During Ultraviolet-B Radiation
Sparks et al.
Arch Dermatol 1985;121:1107-1107.
ABSTRACT  

Erythema Resulting From Suberythemogenic Doses of Ultraviolet Radiation and Methotrexate
LeVine
Arch Dermatol 1981;117:656-658.
ABSTRACT  

Fever Caused by Hydroxyurea
Bauman et al.
Arch Intern Med 1981;141:260-261.
ABSTRACT  

Photochemotherapy for Psoriasis
Roenigk and Martin
Arch Dermatol 1977;113:1667-1670.
ABSTRACT  

Mycophenolic Acid for Psoriasis
Lynch and Roenigk
Arch Dermatol 1977;113:1203-1208.
ABSTRACT  

An Appraisal of Current Systemic Chemotherapy for Psoriasis
Farber et al.
Arch Dermatol 1976;112:1679-1688.
ABSTRACT  

Photochemotherapy for Psoriasis With Orally Administered Methoxsalen
Wolff et al.
Arch Dermatol 1976;112:943-950.
ABSTRACT  

Systemic Chemotherapy For Psoriasis: A National Survey
Bergstresser et al.
Arch Dermatol 1976;112:977-981.
ABSTRACT  

Immunosuppressive and Cytotoxic Drugs in Dermatology
Dantzig
Arch Dermatol 1974;110:393-406.
ABSTRACT